These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 37268507)

  • 1. Insulin-like growth factor-1 replacement therapy after extremely premature birth: An opportunity to optimize lifelong lung health by preserving the natural sequence of lung development.
    Kramer BW; Abman S; Daly M; Jobe AH; Niklas V
    Paediatr Respir Rev; 2023 Dec; 48():24-29. PubMed ID: 37268507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BPD: Latest Strategies of Prevention and Treatment.
    Durlak W; Thébaud B
    Neonatology; 2024; 121(5):596-607. PubMed ID: 39053447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: study protocol for the international, multicenter, randomized PLUSS trial.
    Manley BJ; Kamlin COF; Donath S; Huang L; Birch P; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Wilson R; Davis PG; McKinlay CJD
    Trials; 2023 May; 24(1):320. PubMed ID: 37161488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: statistical analysis plan for the international, multicenter, randomized PLUSS trial.
    Francis KL; McKinlay CJD; Kamlin COF; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Davis PG; Donath SM; Manley BJ
    Trials; 2023 Nov; 24(1):709. PubMed ID: 37932774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of preterm birth and bronchopulmonary dysplasia on the developing lung: long-term consequences for respiratory health.
    O'Reilly M; Sozo F; Harding R
    Clin Exp Pharmacol Physiol; 2013 Nov; 40(11):765-73. PubMed ID: 23414429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of less invasive surfactant administration versus intubation-surfactant-extubation on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: a single-center, retrospective study from China.
    Xu CC; Bao YY; Zhao JX; Cheng K; Sun L; Wu JY; Wu MY; Zhu JJ
    BMC Pulm Med; 2022 Dec; 22(1):462. PubMed ID: 36471386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Changes in Early Respiratory Support Management on Respiratory Outcomes of Preterm Infants.
    Xie L; Luo X; Li B; Du L; Wang Z; Liu Y; Chen J; Duan S; Yan L; Gao W
    Respir Care; 2022 Oct; 67(10):1310-1319. PubMed ID: 35764345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchopulmonary dysplasia: Rationale for a pathophysiological rather than treatment based approach to diagnosis.
    Stoecklin B; Simpson SJ; Pillow JJ
    Paediatr Respir Rev; 2019 Nov; 32():91-97. PubMed ID: 30745153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prematurity and BPD: what general pediatricians should know.
    Bonadies L; Cavicchiolo ME; Priante E; Moschino L; Baraldi E
    Eur J Pediatr; 2023 Apr; 182(4):1505-1516. PubMed ID: 36763190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic impact of prematurity and bronchopulmonary dysplasia.
    Álvarez-Fuente M; Arruza L; Muro M; Zozaya C; Avila A; López-Ortego P; González-Armengod C; Torrent A; Gavilán JL; Del Cerro MJ
    Eur J Pediatr; 2017 Dec; 176(12):1587-1593. PubMed ID: 28889192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. rhIGF-1/BP3 Preserves Lung Growth and Prevents Pulmonary Hypertension in Experimental Bronchopulmonary Dysplasia.
    Seedorf G; Kim C; Wallace B; Mandell EW; Nowlin T; Shepherd D; Abman SH
    Am J Respir Crit Care Med; 2020 May; 201(9):1120-1134. PubMed ID: 32101461
    [No Abstract]   [Full Text] [Related]  

  • 13. Early Intratracheal Administration of Corticosteroid and Pulmonary Surfactant for Preventing Bronchopulmonary Dysplasia in Preterm Infants with Neonatal Respiratory Distress Syndrome: A Meta-analysis.
    Zhong YY; Li JC; Liu YL; Zhao XB; Male M; Song DK; Bai Y
    Curr Med Sci; 2019 Jun; 39(3):493-499. PubMed ID: 31209823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effects of achieving perinatal interventions on bronchopulmonary dysplasia in preterm infants.
    Chen X; Yuan L; Jiang S; Gu X; Lei X; Hu L; Xiao T; Zhu Y; Dang D; Li W; Cao Y; Du L; Lee SK; Chen C; Zhou W; Zhou J;
    Eur J Pediatr; 2024 Apr; 183(4):1711-1721. PubMed ID: 38231237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antenatal Determinants of Bronchopulmonary Dysplasia and Late Respiratory Disease in Preterm Infants.
    Morrow LA; Wagner BD; Ingram DA; Poindexter BB; Schibler K; Cotten CM; Dagle J; Sontag MK; Mourani PM; Abman SH
    Am J Respir Crit Care Med; 2017 Aug; 196(3):364-374. PubMed ID: 28249118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung injury in preterm neonates: the role and therapeutic potential of stem cells.
    Alphonse RS; Rajabali S; Thébaud B
    Antioxid Redox Signal; 2012 Oct; 17(7):1013-40. PubMed ID: 22400813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surfactant, steroids and non-invasive ventilation in the prevention of BPD.
    Dumpa V; Bhandari V
    Semin Perinatol; 2018 Nov; 42(7):444-452. PubMed ID: 30343941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between serum insulinlike growth factor-1, insulinlike growth factor binding protein-2, and insulinlike growth factor binding protein-3 and nutritional intake in premature infants with bronchopulmonary dysplasia.
    Price WA; Lee E; Maynor A; Stiles AD; Clemmons DR
    J Pediatr Gastroenterol Nutr; 2001 May; 32(5):542-9. PubMed ID: 11429514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology and treatment of bronchopulmonary dysplasia. Current issues.
    Abman SH; Groothius JR
    Pediatr Clin North Am; 1994 Apr; 41(2):277-315. PubMed ID: 8139877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.